A REVIEW: ANTI-DIABETIC ACTIVITY OF HERBAL DRUGS
{ DOWNLOAD AS PDF }
Novo Nordisk, a world leader in insulin and diabetes care, has launched Saxenda (liraglutide 3 mg), the first glucagon-like peptide-1 (GLP-1) receptor agonist the United States. Saxenda is a drug used to treat obesity. Saxenda has approved in the US, EU and Canada.
Bioplastics made from protein sources such as egg albumin and whey may have significant antibacterial properties, scientists, including those of Indian-origin, have found. The findings could eventually lead to their application in plastics used in medical applications such as wound healing dressings, sutures, catheter tubes and drug delivery. The bioplastic materials could also be used for food packaging, researchers said.
[adsense:336x280:8701650588]